As the novel coronavirus and disease it causes, COVID-19, continues to spread, Access Accelerated is closely watching the outbreak and thinking of all those affected. We stand by the health workers and responders who are courageously addressing this evolving situation. We are proud to see Access Accelerated member companies rising to the challenge to support the global response.

This public health emergency underscores the importance of building resilient health systems. The outbreak of respiratory disease caused by the novel coronavirus demands strong health systems that can adapt to manage health crises, while continuing to address the ongoing health needs of the population.

The investment in infrastructure, policy and capacity needed to manage infectious diseases can also support the response to chronic non-communicable diseases, and ultimately will help people live better and healthier lives. Access Accelerated remains committed to uniting the private and public sectors to strengthen health systems in low- and middle-income countries.

Industry Contributions through Access Accelerated

Universal health coverage (UHC) has become an increasingly powerful common cause in global health as countries around the world seek to bring quality care to more of their populations, while protecting them from financial hardship.  UHC is a cornerstone of the United Nations (UN) Sustainable Development Goals (SDGs), and as a central priority in its current general program of work, the World Health Organization (WHO) has committed to achieving UHC for 1 billion people by 2023.

The Access Accelerated approach is anchored in growing global and local momentum to achieve UHC; effectively addressing NCDs is foundational to achieving UHC and crucial to realizing the SDGs. As the growing burden of NCDs continues to put pressure on local health systems’ ability to ensure its people can access equitable, high-quality and affordable health care, Access Accelerated is mobilizing the collective capacity of the biopharmaceutical industry and its partners to address this challenge through our NCD initiatives.

Read the full white paper to learn more

Japanese Companies – Six Cross Cutting Principles

As Japanese engagement in solving global health challenges increases, we asked Access member companies for their perspective on how to put our six cross-cutting principles into practice. These principles lay the foundation for effective design in public health programming, and for our Japanese member companies, are vital for articulating commitments and making an impact.Read More

press releases

Journal of Global Oncology: African School of Pediatric Oncology Initiative: Implementation of a Pediatric Oncology Diploma Program to Address Critical Workforce Shortages in French-Speaking Africa

In 2012, the French African Pediatric Oncology Group established the African School of Pediatric Oncology (EAOP), a training program supported by the Sanofi Espoir Foundation’s My Child Matters program. As part of the EAOP, the pediatric oncology training diploma is a 1-year intensive training program. We present this training and certification program as a model for subspecialty training for low- and middle-income countries.

Access Accelerated Launches New Resource to Share Learnings in Non-Communicable Disease (NCD) Program Design

Access Accelerated in Action shares experiences from 19 member company NCD access programs implemented in collaboration with more than 50 cross-sector partners

Access Accelerated in Action

Access Accelerated is a unique cross-industry collaboration that seeks to reduce barriers to prevention, treatment, and care for non-communicable diseases (NCDs) in low- and middle-income countries (LMICs) through health systems strengthening and alignment with UHC objectives and priorities.


Japan is breaking new ground in efforts to bring global health to the forefront of both private and public sector agendas. As the host of this year’s G20 Summit, Japan is leading the international dialogue on inclusive and sustainable economic growth, and along the way, advocating for universal health coverage (UHC).

In the lead up to the 7th Tokyo International Conference on African Development (TICAD7), which begins this week, this edition of Access Today examines the evolving role Japan is playing in global health and the progress being driven by our member companies. Currently, the seven Access Accelerated member companies headquartered in Japan lead 19 programs addressing five NCDs in low- and middle-income countries (LMICs).
Read More

Access Accelerated returned to Kenya on 28 February and 1 March for the non-communicable diseases (NCD) stakeholder meeting, “Redefining UHC – the Opportunity for NCDs,” cohosted with the Ministry of Health and NCD Alliance Kenya in Naivasha, Kenya.

With representation from the Kenyan government across ministries and attendees that spanned civil society, representatives from 12 Access Accelerated member companies, people living with NCDs (PLWNCDs) and government officials from six African nations, the meeting provided a forum to reflect on progress made and recommit to increasing access to NCD treatment and care in the context of the country’s push toward Universal Health Coverage (UHC).Read More


Access Accelerated at TICAD 2019: Accelerating Sustainable UHC by Improving Access to NCD Care

At the Seventh Tokyo International Conference on African Development (TICAD7), Access Accelerated, in partnership with the Japan Pharmaceutical Manufacturers Association (JPMA), hosted a side event titled, “Accelerating Sustainable UHC by Improving Access to NCD Care,” to explore work currently underway to increase access to non-communicable disease (NCD) care in the context of global momentum for Universal Health Coverage (UHC).

Highlights from Access Accelerated at WHA72

On the margins of the 72nd World Health Assembly, Access Accelerated hosted a side event that convened public-private partnership builders to share practical experiences, challenges, successes and lessons learned in forging strong collaborations in support of Universal Health Coverage.


We believe a life not defined by disease is a life of possibility.